These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2459230)

  • 1. Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
    Kern DE; Peace DJ; Klarnet JP; Cheever MA; Greenberg PD
    J Immunol; 1988 Oct; 141(8):2824-30. PubMed ID: 2459230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for T cell recognition and elimination of retrovirally-transformed cells.
    Greenberg P; Klarnet J; Kern D; Okuno K; Riddell S; Cheever M
    Princess Takamatsu Symp; 1988; 19():287-301. PubMed ID: 2479634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.
    Klarnet JP; Kern DE; Dower SK; Matis LA; Cheever MA; Greenberg PD
    J Immunol; 1989 Apr; 142(7):2187-91. PubMed ID: 2466890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.
    Kern DE; Lachmann LB; Greenberg PD
    J Immunol; 1987 Nov; 139(9):2880-7. PubMed ID: 2959723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.
    Greenberg PD
    J Immunol; 1986 Mar; 136(5):1917-22. PubMed ID: 3485134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni.
    Yamashita T; Boros DL
    J Immunol; 1990 Jul; 145(2):724-31. PubMed ID: 1973188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
    Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
    J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of T cell differentiation factor in syngeneic lymphocyte macrophage culture for cytotoxic T lymphocyte generation.
    Ting CC; Hargrove ME; Loh NN
    J Immunol; 1986 Mar; 136(5):1726-33. PubMed ID: 2936809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W; Schweins E; Chen X; Finn OJ; Cheever MA
    J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of helper cell-independent cytotoxic T lymphocytes is dependent upon L3T4+ helper T cells.
    Roopenian DC; Anderson PS
    J Immunol; 1988 Jul; 141(2):391-7. PubMed ID: 2968398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.